Search

everythinglearnresearchcommunity

for

Search:↓

Mohamed Kandil suggests renaming Polycystic Ovary Syndrome to "Polyfollicular Anovulatory Androgenic Syndrome" to better describe its symptoms, but concerns exist that it may not cover all related issues like obesity and depression.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

About 19.4% of Iranian women in the study have Polycystic Ovary Syndrome, with the most common type involving irregular periods and high male hormone levels, but their heart and metabolic health is similar to women without the condition.

PCOS causes infertility mainly due to hormonal imbalances, insulin resistance, and chronic inflammation.

The conclusion is that obesity should be managed with a slow, balanced approach to diet and exercise, with medication and surgery as additional options, and education and access to care are important.

Understanding Polycystic Ovary Syndrome (PCOS) and its causes can lead to effective treatments.

Certain ESR1 gene variations may affect hormone levels and fat distribution in women with high male hormone levels.

Metformin improves menstrual cycles and hormone levels in women with PCOS, mostly within the first 6 months.

Women with PCOS have heart-related issues not because of obesity, but due to insulin resistance and low adiponectin levels.

Hormone imbalances from the pituitary, thyroid, and adrenal glands can cause infertility, but treating these disorders can improve fertility.

Flutamide worked better than finasteride for reducing excessive hair growth in women, but had more side effects.

Finasteride reduces hair growth better, but spironolactone has more side effects.

All three treatments reduce hirsutism, but spironolactone works best long-term.

Low-dose finasteride effectively treats hirsutism, is safe, and cost-effective.

Finasteride reduces hair growth and is safe for women with excessive hair.

Anti-IL-1 treatments might help with certain types of hair loss in people with high inflammation.

Blocking IL-1 could help treat some hair loss conditions; alopecia affects liver detox systems; spironolactone is better than finasteride for female hair growth; focusing on the catagen hair phase could lead to new alopecia treatments.

Alopecia patients have a less active liver monoxygenase system, which can be treated with photochemotherapy and system inducers.

Spironolactone is more effective than finasteride in treating excessive hair growth in women.

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

Early diagnosis and treatment are key to managing health risks in teens with PCOS.

Chemicals and body size might change when puberty starts and progresses, but more research is needed to confirm this.

People with PCOS, especially if obese, often have NAFLD, linked to obesity, insulin resistance, and high androgen levels.

Finasteride effectively reduces hair growth in women with idiopathic hirsutism, but requires careful contraception during treatment.

Obese women with PCOS show a male-like pattern in certain fat tissue gene expressions.

Antiandrogen treatments combined with oral contraceptives can help manage hair growth and hair loss in women with PCOS.

Subcutaneous contraceptives can cause side effects like menstrual changes, headaches, weight gain, and pain at the implant site.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

Testosterone replacement may help postmenopausal women with sexual function and bone density, but suitable treatments are limited.

Women with moderate body hair have higher levels of certain hormones and may benefit from treatment that increases sex hormone-binding protein.